Search research articles
Contact Us
Filters
Showing results (161-170 of 192) with videos related to
Page
of 20
Sort By:
Annals of General Psychiatry
|
February 29, 2024
Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine
Angela T H Kwan, Gia Han Le, Ziji Guo, et al.
Psychopharmacology
|
January 23, 2021
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
Jason Ng, Leanna M W Lui, Joshua D Rosenblat, et al.
CNS Spectrums
|
December 10, 2024
A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gain - CORRIGENDUM
Trisha Menon, Serene Lee, Xuan Yi Gong, et al.
Infectious Diseases (London, England)
|
March 14, 2022
Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research
Felicia Ceban, Alexia Leber, Muhammad Youshay Jawad, et al.
Journal of Psychiatric Research
|
June 18, 2023
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review
Daniel H Cooper, Ranuk Ramachandra, Felicia Ceban, et al.
Acta Psychiatrica Scandinavica
|
December 1, 2025
Effects of Intravenous Ketamine on Posttraumatic Stress Disorder (PTSD): A Systematic Review
Liyang Yin, Andy Lu, Gia Han Le, et al.
CNS Spectrums
|
October 21, 2022
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia
Muhammad Youshay Jawad, Shakila Meshkat, Aniqa Tabassum, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
October 8, 2020
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
Orly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Journal of Affective Disorders
|
July 16, 2020
Corrigendum to "Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review." J Affect Disord. 241 (2018) 519-532
Yena Lee, Renee-Marie Ragguett, Rodrigo B Mansur, et al.
Journal of Affective Disorders
|
August 29, 2018
Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review
Yena Lee, Renee-Marie Ragguett, Rodrigo B Mansur, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 192) with videos related to
Sort By:
Page
of 20
Annals of General Psychiatry
|
February 29, 2024
Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine
Angela T H Kwan, Gia Han Le, Ziji Guo, et al.
Psychopharmacology
|
January 23, 2021
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
Jason Ng, Leanna M W Lui, Joshua D Rosenblat, et al.
CNS Spectrums
|
December 10, 2024
A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gain - CORRIGENDUM
Trisha Menon, Serene Lee, Xuan Yi Gong, et al.
Infectious Diseases (London, England)
|
March 14, 2022
Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research
Felicia Ceban, Alexia Leber, Muhammad Youshay Jawad, et al.
Journal of Psychiatric Research
|
June 18, 2023
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review
Daniel H Cooper, Ranuk Ramachandra, Felicia Ceban, et al.
Acta Psychiatrica Scandinavica
|
December 1, 2025
Effects of Intravenous Ketamine on Posttraumatic Stress Disorder (PTSD): A Systematic Review
Liyang Yin, Andy Lu, Gia Han Le, et al.
CNS Spectrums
|
October 21, 2022
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia
Muhammad Youshay Jawad, Shakila Meshkat, Aniqa Tabassum, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
October 8, 2020
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
Orly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Journal of Affective Disorders
|
July 16, 2020
Corrigendum to "Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review." J Affect Disord. 241 (2018) 519-532
Yena Lee, Renee-Marie Ragguett, Rodrigo B Mansur, et al.
Journal of Affective Disorders
|
August 29, 2018
Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review
Yena Lee, Renee-Marie Ragguett, Rodrigo B Mansur, et al.
Page
of 20